Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A prospective, phase III trial to evaluate the efficacy and safety of HIV vaccine [Biosantech] in patients with HIV infections

Trial Profile

A prospective, phase III trial to evaluate the efficacy and safety of HIV vaccine [Biosantech] in patients with HIV infections

Status: Planning
Phase of Trial: Phase III

Latest Information Update: 18 Mar 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs HIV vaccine (Primary)
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Mar 2016 New trial record
    • 15 Mar 2016 According to Biosantech media release, based on the results of its IIa trial (see CTP700229617), the company will put forward request for this phase III trial of its anti-HIV vaccine for an extensive evaluation during 2016. Subject to approval by the regulatory authorities and the results of this trial, an initial anti-HIV vaccine would be available from the H2 of 2018. The company intends to request a MAA for its anti-HIV vaccine in second half of 2018.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top